It is important to note that while studies have explored the relationship between AD-related pathology and excitatory GABAergic switches, previous research has explored the link between non-pathogenic amyloid precursor protein (APP) and alterations in GABAergic signaling. This evidence concerns the gene APP and Alzheimer disease.